Vincerx Pharma, Inc. (VINC)
VINC moved a median of -0.47% 30 minutes after news, and -1.91% by the close. How VINC actually reacts to news — the realized, point-in-time move the market made, measured across 143 labeled events over the last three years with zero look-ahead.
VINC’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 37% | 136 |
| 30-min | -0.47% | 43% | 143 |
| 60-min | -0.87% | 41% | 143 |
| to close | -1.91% | 27% | 143 |
| Middle 50% of VINC reactions | -4.49% to +1.07% |
|---|---|
| Median reaction (30-min) | -0.47% |
| Measured reactions | 143 |
Half of all Vincerx Pharma, Inc. news events land between -4.49% and +1.07% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when VINC moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to VINC's baseline. Nothing else.
Recent VINC events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form DEFA14A Vincerx Pharma, Inc. | SEC filing · Form DEFA14A | SEC EDGAR | +0.00% | -1.91% | |
| Vincerx Pharma, Inc. Announces Additional Adjournment of Special Meeting - Urges Stockholders to Vote FOR Approval of Dissolution Proposal | Press release | GlobeNewswire | +0.00% | -1.91% | |
| Form 8-K Vincerx Pharma, Inc. For: Jun 30 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +7.66% | |
| Form DEFA14A Vincerx Pharma, Inc. | SEC filing · Form DEFA14A | SEC EDGAR | +0.00% | +7.66% | |
| Vincerx Pharma, Inc. Urges Stockholders to Vote FOR Approval of Dissolution Proposal and Announces Potential Range for Distributions to Stockholders | Press release | GlobeNewswire | +0.00% | +7.66% | |
| Form DEFA14A Vincerx Pharma, Inc. | SEC filing · Form DEFA14A | SEC EDGAR | +0.00% | -7.06% | |
| Vincerx Pharma, Inc. Announces Adjournment of Special Meeting - Will Reconvene Meeting on July 16, 2025 to Secure Votes Needed to Approve Dissolution Proposal | Press release | GlobeNewswire | +0.00% | -7.06% | |
| Form DEFA14A Vincerx Pharma, Inc. | SEC filing · Form DEFA14A | SEC EDGAR | -17.37% | -9.43% | |
| Form 10-Q Vincerx Pharma, Inc. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | +10.00% | |
| Form DEF 14A Vincerx Pharma, Inc. For: Jun 18 | SEC filing · Form DEF | SEC EDGAR | +0.00% | -2.00% | |
| Form EFFECT Vincerx Pharma, Inc. | SEC filing · Form EFFECT | SEC EDGAR | +0.38% | +3.58% | |
| Form POS AM Vincerx Pharma, Inc. | SEC filing · Form POS | SEC EDGAR | -8.18% | -3.46% | |
| Form S-8 POS Vincerx Pharma, Inc. | SEC filing · Form S-8 | SEC EDGAR | -8.18% | -3.46% | |
| Form PRE 14A Vincerx Pharma, Inc. For: Apr 30 | SEC filing · Form PRE | SEC EDGAR | -4.54% | -7.27% | |
| Form 25 Vincerx Pharma, Inc. | SEC filing · Form 25 | SEC EDGAR | -17.63% | -6.10% | |
| Form 8-K Vincerx Pharma, Inc. For: Apr 14 | SEC filing · Form 8-K | SEC EDGAR | +1.94% | -25.94% | |
| Vincerx Pharma, Inc. Announces Intent to Delist from Nasdaq and Deregister with the SEC | Press release | GlobeNewswire | +1.94% | -25.94% | |
| Form 8-K Vincerx Pharma, Inc. For: Apr 07 | SEC filing · Form 8-K | SEC EDGAR | -1.85% | -1.46% | |
| Vincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down Activities | Press release | GlobeNewswire | +0.00% | +3.22% | |
| Form EFFECT Vincerx Pharma, Inc. | SEC filing · Form EFFECT | SEC EDGAR | -1.56% | +3.09% | |
| Form S-3/A Vincerx Pharma, Inc. | SEC filing · Form S-3 | SEC EDGAR | +1.27% | +11.98% | |
| Form 10-K Vincerx Pharma, Inc. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | -1.11% | -1.91% | |
| Form 8-K Vincerx Pharma, Inc. For: Mar 14 | SEC filing · Form 8-K | SEC EDGAR | -4.39% | -36.92% | |
| Vincerx Pharma Announces Non-Binding Letter of Intent for Business Combination with QumulusAI | Press release | GlobeNewswire | -4.39% | -36.92% | |
| Form 8-K Vincerx Pharma, Inc. For: Feb 25 | SEC filing · Form 8-K | SEC EDGAR | -0.74% | -6.16% | |
| Vincerx Pharma Announces Termination of Reverse Merger Term Sheet and Evaluation of Strategic Alternatives | Press release | GlobeNewswire | -0.74% | -6.16% | |
| Form 8-K Vincerx Pharma, Inc. For: Feb 11 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -0.78% | |
| Form 8-K Vincerx Pharma, Inc. For: Jan 31 | SEC filing · Form 8-K | SEC EDGAR | -1.47% | +2.94% | |
| Form DEFA14A Vincerx Pharma, Inc. | SEC filing · Form DEFA14A | SEC EDGAR | -1.47% | +2.94% | |
| Form DEFA14A Vincerx Pharma, Inc. | SEC filing · Form DEFA14A | SEC EDGAR | +0.00% | -0.66% | |
| Vincerx Pharma, Inc. and Oqory, Inc. Highlight Promising Data for Oqory’s TROP2 Antibody Drug Conjugate, OQY-3258 | Press release | GlobeNewswire | -5.58% | -20.81% | |
| Form S-3 Vincerx Pharma, Inc. | SEC filing · Form S-3 | SEC EDGAR | -1.20% | -0.60% | |
| Form 8-K Vincerx Pharma, Inc. For: Jan 23 | SEC filing · Form 8-K | SEC EDGAR | -4.82% | -3.70% | |
| Form DEFA14A Vincerx Pharma, Inc. | SEC filing · Form DEFA14A | SEC EDGAR | -4.82% | -3.70% | |
| Vincerx Pharma, Inc. Announces Reverse Stock Split | Press release | GlobeNewswire | -4.82% | -3.70% | |
| Form 8-K Vincerx Pharma, Inc. For: Jan 21 | SEC filing · Form 8-K | SEC EDGAR | +0.53% | -15.29% | |
| Form 8-K Vincerx Pharma, Inc. For: Jan 10 | SEC filing · Form 8-K | SEC EDGAR | -3.62% | -1.74% | |
| VINC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Vincerx Pharma, Inc. Is Fair to Shareholders | Press release | Business Wire | -11.47% | -32.93% | |
| Form 8-K Vincerx Pharma, Inc. For: Dec 20 | SEC filing · Form 8-K | SEC EDGAR | +9.62% | +4.54% | |
| Vincerx Pharma Enters into a Binding Term Sheet for a Strategic Merger with Oqory, Inc. | Press release | GlobeNewswire | +9.62% | +4.54% | |
| Form DEF 14A Vincerx Pharma, Inc. For: Jan 16 | SEC filing · Form DEF | SEC EDGAR | +0.00% | -6.96% | |
| Form 8-K Vincerx Pharma, Inc. For: Dec 02 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +4.48% | |
| Vincerx Pharma to Implement Cost-Controls to Support Advancing Phase 1 Study of VIP943 | Press release | GlobeNewswire | -0.34% | -6.86% | |
| Form 8-K Vincerx Pharma, Inc. For: Nov 25 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +0.39% | |
| Form 10-Q Vincerx Pharma, Inc. For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | +1.16% | -1.91% | |
| Form 8-K Vincerx Pharma, Inc. For: Nov 12 | SEC filing · Form 8-K | SEC EDGAR | +0.61% | -1.91% | |
| Vincerx Pharma Reports Third Quarter 2024 Financial Results | Press release | GlobeNewswire | +0.61% | -1.91% | |
| Form PRE 14A Vincerx Pharma, Inc. For: Dec 19 | SEC filing · Form PRE | SEC EDGAR | +0.78% | -0.37% | |
| Form 8-K Vincerx Pharma, Inc. For: Oct 07 | SEC filing · Form 8-K | SEC EDGAR | -10.47% | -36.33% | |
| Vincerx Reports Positive Initial Clinical Data from Ongoing VIP943 Phase 1 Dose-Escalation Study and Provides Pipeline and Corporate Updates | Press release | GlobeNewswire | -10.47% | -36.33% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the VINC section they belong to.
Where else VINC is measured.
VINC earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Vincerx Pharma, Inc.'s median reaction calculated?
Every labeled VINC news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 143 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 43% of VINC's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does VINC's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.